Frontlight ResearchEarly access
Lung cancer trials, also abroad
2,747 open Lung cancer trials worldwide. Travel and costs are your own unless the study pays them; ask the study team first.
| Country | Open trials |
|---|---|
| China | 1144 |
| United States | 901 |
| France | 316 |
| Spain | 275 |
| Italy | 272 |
| All other countries |
The same trial often runs in several countries
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004) has 1 site in Costa Rica and runs in 30 countries. If a site near you is full, another one may still take people.
See A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004) in all 30 countries